Yunlim Kim

Seoul, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

Oncolytic adenovirus co-expressing IL-12 and shVEGF potentiates immune checkpoint blockade for treatment of renal cell carcinoma: in vitro, organ-on-a-chip, and in vivo evaluation.

Oncolytic adenovirus co-expressing IL-12 and shVEGF potentiates immune checkpoint blockade for treatment of renal cell carcinoma: in vitro, organ-on-a-chip, and in vivo evaluation.

Journal: Molecular medicine (Cambridge, Mass.)

Published: March 06, 2026

Prostate cancer diagnosis using sensitive and sophisticated machine learning classifiers based on non-invasive urinary RNA biomarkers (PCASSO).

Prostate cancer diagnosis using sensitive and sophisticated machine learning classifiers based on non-invasive urinary RNA biomarkers (PCASSO).

Journal: Scientific reports

Published: July 22, 2025

Stereotactic Body Radiation Therapy for Primary Renal Cancer and Genetic Markers of Response: A Phase 2 Trial.

Stereotactic Body Radiation Therapy for Primary Renal Cancer and Genetic Markers of Response: A Phase 2 Trial.

Journal: European urology oncology

Published: February 26, 2025

Distinct prognostic and molecular profiles of fat versus vein invasion in T3a renal cell carcinoma.

Distinct prognostic and molecular profiles of fat versus vein invasion in T3a renal cell carcinoma.

Journal: British journal of cancer

Published: February 03, 2025

Effects of bipolar irreversible electroporation with different pulse durations in a prostate cancer mouse model.

Effects of bipolar irreversible electroporation with different pulse durations in a prostate cancer mouse model.

Journal: Scientific reports

Published: December 12, 2023

Prostate cancer therapy using immune checkpoint molecules to target recombinant dendritic cells.

Prostate cancer therapy using immune checkpoint molecules to target recombinant dendritic cells.

Journal: Investigative and clinical urology

Published: October 19, 2023

A novel biguanide derivative, IM176, induces prostate cancer cell death by modulating the AMPK-mTOR and androgen receptor signaling pathways.

A novel biguanide derivative, IM176, induces prostate cancer cell death by modulating the AMPK-mTOR and androgen receptor signaling pathways.

Journal: Prostate international

Published: September 28, 2022

Glucocorticoid receptor and androgen receptor-targeting therapy in patients with castration-resistant prostate cancer.

Glucocorticoid receptor and androgen receptor-targeting therapy in patients with castration-resistant prostate cancer.

Journal: Frontiers in oncology

Published: June 18, 2022

Effects of different applied voltages of irreversible electroporation on prostate cancer in a mouse model.

Effects of different applied voltages of irreversible electroporation on prostate cancer in a mouse model.

Journal: Scientific reports

Published: June 16, 2022

A novel platform using homobifunctional hydrazide for enrichment and isolation of urinary circulating RNAs.

A novel platform using homobifunctional hydrazide for enrichment and isolation of urinary circulating RNAs.

Journal: Bioengineering & translational medicine

Published: February 15, 2022

Chimeric nanocomposites for the rapid and simple isolation of urinary extracellular vesicles.

Chimeric nanocomposites for the rapid and simple isolation of urinary extracellular vesicles.

Journal: Journal of extracellular vesicles

Published: July 29, 2021

Novel platinum bipolar electrode for irreversible electroporation in prostate cancer: preclinical study in the beagle prostate.

Novel platinum bipolar electrode for irreversible electroporation in prostate cancer: preclinical study in the beagle prostate.

Journal: Scientific reports

Published: April 12, 2021

Showing 1-12 of 26

Last Updated: 09/26/2026